Table 3.
Positive and negative predictive values of panels used in the identification of endocervical adenocarcinoma.
| Panel | PPV | 95% CI |
NPV | 95% CI |
||
|---|---|---|---|---|---|---|
| Lower Limit | Upper Limit | Lower Limit | Upper Limit | |||
| Traditional | 85.71 | 0.42 | 0.99 | 96.39 | 0.89 | 0.99 |
| Traditional plus PAX8 | 100 | 0.15 | 1.00 | 92.05 | 0.84 | 0.96 |
| Lean 1 | 77.78 | 0.39 | 0.97 | 97.53 | 0.91 | 0.99 |
| Lean 2 | 85.71 | 0.42 | 0.99 | 96.39 | 0.89 | 0.99 |
| New Panel | 100 | 0.15 | 1.00 | 92.05 | 0.84 | 0.96 |
PPV: positive predictive value. NPV: negative predictive value. CI: confidence interval.
Traditional Panel: CEA, vimentin, p16, ER and PR; Traditional Panel plus PAX8: CEA, vimentin, p16, ER, PR and PAX8; Lean 1: vimentin, p16 and ER; Lean 2: CEA, p16 and ER; New Panel: CEA, p16, ER, PAX8 and CAIX.